Press Releases August 11, 2026 05:00 PM

LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LifeVantage Grants Inducement Awards to New CEO under Nasdaq Rule

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
LFVN

LifeVantage Corporation announced that its Board of Directors granted inducement awards to its new President and CEO, Terrence Moorehead, under its 2026 New Employee Long-Term Incentive Plan, including restricted stock units and performance-based restricted stock units vesting over three years based on revenue and profitability targets.

LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LFVN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • LifeVantage appointed Terrence Moorehead as new CEO and granted him inducement awards including RSUs and PSUs.
  • The inducement awards are subject to vesting conditions tied to continued service and company performance measures like revenue and Adjusted EBITDA margin.
  • LifeVantage is a US-based nutrigenomics company specializing in health supplement products marketed via a consultant sales model.

SALT LAKE CITY, Aug. 11, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”) today announced that its Board of Directors granted inducement awards to Terrence Moorehead, the Company’s new President and Chief Executive Officer, under the Company’s 2026 New Employee Long-Term Incentive Plan (the “New Employee Plan”) as an inducement material to Mr. Moorehead’s employment in accordance with Nasdaq Listing Rule 5635(c)(4).

The awards were granted on August 6, 2026 and consist of (i) a grant of restricted stock units (“RSUs”) representing 308,642 shares of the Company’s common stock, which will vest in three equal annual installments starting on the one-year anniversary of their grant date and (ii) a grant of performance-based restricted stock units (“PSUs”) representing 540,123 shares of the Company’s common stock, which will vest over a three year period based on the achievement of certain revenue and Adjusted EBITDA margin targets, in each case, subject to continued service with the Company through the applicable vesting dates.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics-the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the MindBody GLP-1 System®, the comprehensive gut activator P84, the Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.

Investor Relations Contacts:

Reed Anderson, ICR 
(646) 277-1260
[email protected]


Risks

  • Performance-based awards depend on meeting revenue and profitability targets, which may not be achieved impacting executive incentives.
  • Continued service condition means awards hinge on Mr. Moorehead's tenure, posing risk if leadership changes occur.
  • The company's multi-level marketing business model can be affected by regulatory scrutiny, market trends, and consumer preferences, influencing financial performance.

More from Press Releases

JFB and XTEND Announce SEC Declares Form S-4 Effective Aug 11, 2026 Westport Reports Second Quarter 2026 Financial Results Aug 11, 2026 Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results Aug 11, 2026 Siebert Reports Second Quarter 2026 Financial Results Aug 11, 2026 Mount Logan Capital Inc. Announces Second Quarter 2026 Financial Results Aug 11, 2026